Biological Intellectual Property Protection Act of 2025
Congress Moves to Require Licenses for Exporting Digital Synthetic DNA/RNA Designs to Foreign Entities of Concern
Stalled
No legislative action in over 90 days.
↔Companion bill: Congress proposes export licenses for synthetic DNA/RNA sequence files to limit access by foreign entities of concernLegislative Progress
Key Points
- Would require the Commerce Department to set up a license rule for exporting certain digital synthetic DNA or RNA sequences to “foreign entities of concern.”
- Covers digital files that describe human-made (or AI-designed) DNA/RNA sequences, not just physical lab materials.
- The license rule would need to be in place within 1 year after the bill becomes law, which could add new paperwork and delays for some research and biotech deals.
- Includes an exception for information that is already treated as publicly available under existing export rules, so normal open scientific publishing may not be covered.
- Main goal is to reduce the risk of intellectual property theft and national security harm from adversaries getting sensitive synthetic biology designs.
Impact Analysis
Govbase has not yet run an impact analysis on this legislation.
Milestones
Referred to the House Committee on Foreign Affairs.
Introduced in House
The bill was officially filed and given a number. It now enters the legislative queue.
Votes
No votes have been recorded for this legislation yet.
Related News
4 articles
Cotton Introduces Bill to Protect American Biotech Innovation from Communist China
Announces the Biological Intellectual Property Protection Act of 2025 and describes a proposed Commerce licensing requirement for exports/transfers of designed synthetic DNA/RNA sequences to foreign entities of concern, with research/publication carve-outs.
Press Release: Cotton Introduces Legislation to Safeguard American Biotech Innovation from Chinese Theft
Roundup summarizing the bill’s stated purpose and core mechanism: a license requirement for exporting/transfer of synthetic DNA/RNA digital sequences to foreign entities of concern, plus exemptions tied to existing export rules.
New Bill: Representative Warren Davidson introduces H.R. 6624: Biological Intellectual Property Protection Act of 2025
Summarizes companion House legislation (H.R. 6624) creating a licensing requirement for exporting/transferring digital synthetic DNA/RNA sequences to foreign entities of concern, referencing exceptions under existing export regulations.
Source Information
Document Type
Congressional Bill
Official Title
Biological Intellectual Property Protection Act of 2025
Data Sources
Sponsor
Cosponsors
(10)Analysis generated by AI. Always verify with official sources.